← Back to Search

Cell Therapy

ERIPTO Protocol for Knee Arthritis (ERIPTO Trial)

N/A
Waitlist Available
Led By Mohammed M Qureshi, DO, CAQSM, MRO
Research Sponsored by Affinity Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial is comparing two different treatments for post-traumatic osteoarthritis of the knee, one involving a bone marrow aspirate concentrate (BMAC) and one involving the ERIPTO protocol. The investigators will be looking at various factors such as time frame from initial injury, type of injury, gender, and age when injury first occurred to see if there is a correlation with the severity of osteoarthritis.

Eligible Conditions
  • Knee Arthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Radiographic Changes
Secondary study objectives
Subjective Knee Symptom Changes

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ERIPTO ProtocolExperimental Treatment1 Intervention
Protocol arm actively being studied
Group II: BMAC onlyActive Control1 Intervention
bone marrow aspirate concentrate only arm

Find a Location

Who is running the clinical trial?

Affinity Health Research InstituteLead Sponsor
The Center for Primary Care and Sports MedicineUNKNOWN
Genesis Orthopedics and Sports MedicineUNKNOWN
~8 spots leftby Nov 2025